New radiation technique aims to hit cancer harder with fewer side effects

NCT ID NCT05880667

Recruiting now Disease control Sponsor: Fox Chase Cancer Center Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times

Summary

This early-phase trial tests a type of radiation that adapts to the tumor's shape and location, allowing doctors to give a higher dose to cancer in the abdomen or pelvis while keeping severe side effects under 10%. About 30 adults with metastatic solid tumors (any type) that need local control or symptom relief will receive this treatment. The main goal is to see if this approach is safe and can deliver more radiation without causing serious harm.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASM - SOFT TISSUE PELVIS MALIGNANT SECONDARY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fox Chase Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19111, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MALIGNANT NEOPLASM OF STOMACH NEOPLASM - SOFT TISSUE PELVIS MALIGNANT SECONDARY